• Applikationsbericht

Analytical LC-MS Platform Methodologies to Support Upstream Bioprocess Optimization

Analytical LC-MS Platform Methodologies to Support Upstream Bioprocess Optimization

Yun Alelyunas, Julie Wushensky, Jurgen Sanes, Mark Wrona, Rui Chen

Waters Corporation, United States

Published on October 10, 2025

PDF herunterladen PDF herunterladen

Introduction

Effective process monitoring and product critical quality attribute analysis are critical components for a given upstream process optimization operation. It is desirable that these analyses can be carried out by multi-disciplined scientists who can easily perform the analysis in the absence of deep discipline-based understanding. For liquid chromatography-mass spectrometry (LC-MS) analysis, high throughput is expected to ensure quick turn-around time, such that the results can be fed back to the cell culture design of experiment (DOE) model for a fast design-make-test cycle.

720008953en-f1

At Waters Immerse Delaware (WID) laboratory, cross-disciplinary scientists are assembled to include cell culture engineers and traditional LC-MS analytical scientists. In proof-of-concept studies, the team conducts upstream bioprocess optimization experiments for a monoclonal antibody (mAb) producing CHO cell line using an Ambr® 250 eight modular bioreactor system. The resulting harvested cell culture fluid (HCCF) samples are subject to LC and LC-MS analysis for process and product critical attribute measurements. These include titer, aggregation and impurities determination, cell culture media components and metabolite analysis, intact protein mass determination and major glycosylation profiling, reduced protein to heavy chain for major glycosylation profiling, and released glycan analysis, among others. All these analyses are carried out using ACQUITY™ LC and/or BioAccord™ LC-MS systems. BioAccord is a high-resolution mass spectrometer system with small footprints and user-friendly instrument control and operation. This allows the instrument to fit in bioprocess labs easily and enables scientists who have minimal training in LC-MS technology to carry out analysis quickly. The WID lab is also equipped with an Andrew+™ Robot with intuitive OneLab™ software for writing automation protocols; this allows for the automation of both routine and complicated sample preparations, such as ProA purification or released glycan analysis. A summary of major instruments in WID laboratory that are involved in the present study are shown on the title page.

This application note is a compilation of optimized automation and analytical methods for ease of reference. Method optimization resulted in both reduced analysis time and enhanced operational efficiency. These include sharing mobile phases among multiple analyses and using commercially available mobile phases for minimizing preparations. Assays included are summarized in the table below:

summary of assays included in this application note
Table 1. summary of assays included in this application note.

Experimental

I. Sample Collection and Distribution

  • In a typical DOE designed experiment in upstream process optimization, HCCF could be collected daily for a 14-day fed-batch experiment. After centrifugation and filtration, the clarified samples would then be stored in 1.4 mL tubes in 96 well format at -80 °C.
  • These clarified samples are subject to analysis such as protein titer, amino acids and metabolites, and aggregation screening. For product critical attributes such as intact protein, reduced protein, released glycan and other assays, the product protein is purified based on Protein A affinity purification using Andrew+ Robots.
(A) Representative sample placement for a 14-day fed-batch experiment using Ambr 250 in a 96 well plate format. Samples are arrayed by day of harvest on the x-axis, and by bioreactor vessel on the y-axis. (B) HCCF sampling from an Ambr 250 modular system
Figure 2. (A) Representative sample placement for a 14-day fed-batch experiment using Ambr 250 in a 96 well plate format. Samples are arrayed by day of harvest on the x-axis, and by bioreactor vessel on the y-axis. (B) HCCF sampling from an Ambr 250 modular system.
HCCF sample distribution volume consumed for various process and product attributes measurements. A total of 150 µL of HCCF is needed
Figure 3. HCCF sample distribution volume consumed for various process and product attributes measurements. A total of 150 µL of HCCF is needed.

II. Titer Determination using Protein A Affinity Chromatography

  • Protein titer measurement is based on Protein A affinity chromatography on an ACQUITY Premier LC-UV System. The run time is 3 minutes. Samples are centrifuge- and filter-clarified HCCF solutions without further preparation. 

LC Method Conditions I

720008953en-1b

Gradient Table

720008953en-1
Overlaid chromatograms and calibration curve of NISTmAb standard solution with concentration ranging from 0.1 mg/mL to 10 mg/mL at 1 uL injection volume, collected with LC-UV using Waters BioResolve Protein A Affinity Column
Figure 4. Overlaid chromatograms and calibration curve of NISTmAb standard solution with concentration ranging from 0.1 mg/mL to 10 mg/mL at 1 uL injection volume, collected with LC-UV using Waters BioResolve Protein A Affinity Column.
Calibration range and peak characteristics of NISTmAb at 10 mg/mL (g/L)
Table 2. Calibration range and peak characteristics of NISTmAb at 10 mg/mL (g/L).

III. Cell Culture Media and Metabolites Analysis

  • Spent culture media and metabolites analyses are based on reversed-phase chromatography using Waters ACQUITY Premier HSS T3 Column on BioAccord System. Samples are centrifuge- and filter-clarified HCCF solution, diluted 20 to greater than 400 times using 0.1% formic acid (FA). Run time is 9 minutes.
  • The method includes 220+ compounds library and guided workflow for ease of data processing/reporting.

LC-MS Method Conditions I

720008953en-2b

Gradient Table

720008953en-3
Extracted ion chromatogram (XIC) of 26 compounds in the amino acid cell culture standard kits. Two isobaric compound pairs, isoleucine/leucine and 2-amino/4-amino butyric acid are baseline separated
Figure 5. Extracted ion chromatogram (XIC) of 26 compounds in the amino acid cell culture standard kits. Two isobaric compound pairs, isoleucine/leucine and 2-amino/4-amino butyric acid are baseline separated.

IV. Aggregation/Fragmentation Measurement Based on SEC Column

Two methods are available for aggregate and fragment measurement using size-exclusion chromatography (SEC) on ACQUITY Premier LC-UV System.

  • The screening method is used for rapid throughput with 4 minutes run time.
  • The characterization method uses a longer column for purified final product when separation of fragment impurities is important. 

LC-UV Conditions - Screening

720008953en-3b

LC-UV Conditions - Characterization

720008953en-4b
(A) Raw spent media sample from mAb producing CHO-cell line using screening method. (B) (Top) mAb size variant standard (p/n 186009429), (bottom) NISTmAb (RM8671 ext. NIST.gov) using characterization method
Figure 6. (A) Raw spent media sample from mAb producing CHO-cell line using screening method. (B) (Top) mAb size variant standard (p/n 186009429), (bottom) NISTmAb (RM8671 ext. NIST.gov) using characterization method.

V. Intact Protein Analysis

  • Intact protein analysis uses ACQUITY Premier Protein BEH C4 Column on BioAccord HRMS System. Run time is 5 minutes.
  • Clarified HCCF media samples or Protein A purified samples using Andrew+ Pipetting Robot.

LC-MS Method Conditions II (Protein Analysis)

720008953en-5b

Gradient Table

720008953en-4
(Left) Total ion chromatogram and TUV trace of NISTmAb as 1 mg/ mL solution with 2 µL injection volume. (Right) Observed and deconvoluted MS spectra
Figure 7. (Left) Total ion chromatogram and TUV trace of NISTmAb as 1 mg/ mL solution with 2 µL injection volume. (Right) Observed and deconvoluted MS spectra.

VI. Reduced Protein Analysis via LC and HC (DTT Reduction)

  • Reduced protein analysis uses ACQUITY Premier Protein BEH C4 Column on BioAccord System. Run time is 5 minutes.
  • Sample is prepared using guanidine denaturation and DTT reduction to produce light chain (LC) and heavy chain (HC).

LC-MS Method Conditions III (DTT Reduction)

720008953en-6b

Gradient Table

720008953en-5
(Left) Total ion chromatogram of NISTmAb after DTT reduction to form heavy chain (HC) and light chain (LC). (Right) observed and deconvoluted spectra of heavy chain
Figure 8. (Left) Total ion chromatogram of NISTmAb after DTT reduction to form heavy chain (HC) and light chain (LC). (Right) observed and deconvoluted spectra of heavy chain.

VII Released Glycan Analysis

  • Released glycan analysis is based on HILIC chromatography using BioAccord System. Run time is 10 minutes. Samples are prepared using Waters GlycoWorks™ RapiFluor-MS™ released N-Glycan Kits using Andrew+ Pipetting Robots. 

LC-MS Method Conditions IV (Glycan Analysis)

720008953en-7b

Gradient Table

720008953en-6c
(A) Extracted ion chromatogram of RapiFluor-MS Glycan Performance Test Standard (p/n 186007983). (B) Extracted ion chromatogram of RapiFluor-MS high Mannose Standard (p/n 186008317)
Figure 9. (A) Extracted ion chromatogram of RapiFluor-MS Glycan Performance Test Standard (p/n 186007983). (B) Extracted ion chromatogram of RapiFluor-MS high Mannose Standard (p/n 186008317).

VIII. Protein A Purification using Andrew+ Robot Supply Guide

  • Dominos, supplies, and consumables used in Protein A purification on Andrew+ Robot is summarized in tables below. More detailed information on the purification can be found in Waters application note “Analytical Scale 96-well Protein A Affinity Resin-Based Purification using Andrew+ Automation Robot Supporting Upstream Bioprocessing”.
Dominos, supplies, and consumables used in Protein A purification on Andrew+ Robot
Table 3. Dominos, supplies, and consumables used in Protein A purification on Andrew+ Robot.
(A) Placement of Andrew+ dominos for the ProA affinity purification of 96 samples. Position 1&2, 300 µL pipette tips; 3, Quanrecovery plate; 4, HCCF sample; 5, Extraction+ with filter plate; and 6, reagent trough. Users should follow OneLab screen instruction for the final placement. (B) Dialog box for entering number of samples upon execution of the protocol
Figure 10. (A) Placement of Andrew+ dominos for the ProA affinity purification of 96 samples. Position 1&2, 300 µL pipette tips; 3, Quanrecovery plate; 4, HCCF sample; 5, Extraction+ with filter plate; and 6, reagent trough. Users should follow OneLab screen instruction for the final placement. (B) Dialog box for entering number of samples upon execution of the protocol.
Reagents and their placement on Andrew+ Robot for Protein A purification
Table 4. Reagents and their placement on Andrew+ Robot for Protein A purification.

Reagents and their preparation for Protein A purification on Andrew+ Robot.

  1. Binding/wash buffer: Source Millipore Sigma 10x DPBS, dilute to 1x DPBS using H2O.
  2. ProA resin: The resin comes as 50% resin in 20% ethanol: Follow Cytiva’s instruction, centrifuge at 1000 g for 3 minutes, replace supernatant with 400 mM NaCl in 20% ethanol to 50% resin level. Further dilute with 1xDPBS to 25% resin as working solution. Thoroughly mix prior to transfer to reagent trough. After each use, mark the liquid level on the tube. In next use, if liquid level is reduced due to evaporation, fill to mark with 20% ethanol.
  3. Elution buffer: 100 mM glycine, pH adjusted to 3.0
  4. Neutralization buffer: 1M Tris-HCl, pH 7.5

IX. JMP Add-in for Data Visualization and Analysis

  • In JMP marketplace place, there is a Waters add-in available for download, free-of-charge. The add-in enables data import, organize and display based on analyte class or biotransformation pathways. One example is shown below displaying overlaid plot of amino acids in 8 bioreactors over 14 days of incubation.
Cell culture media and metabolite analysis of an incubation using NISTCHO cell line (RM8675 NIST.gov) showing trending plot of amino acid concentration changes overtime during a 14-day, eight bioreactor Ambr 250 experiment
Figure 11. Cell culture media and metabolite analysis of an incubation using NISTCHO cell line (RM8675 NIST.gov) showing trending plot of amino acid concentration changes overtime during a 14-day, eight bioreactor Ambr 250 experiment.

References

  1. Titer determination based on Protein A affinity chromatography
    —BioResolve Protein A Affinity Columns Care & Use Manual (p/n: 720008817)
    —Lowering Quantitation Limits for mAb Titer Measurements Using Small Volume 3.5 µm Particle-Size Protein-A Affinity Columns (p/n: 720008775)
  2. Aggregation/fragmentation analysis
    —ACQUITY Premier Protein SEC 250 A, 1.7 uM columns Use and Care Manual (p/n: 720007477)
  3. Cell culture and metabolites analysis
    —Monitoring Nutrients and Metabolites in Spent Cell Culture Media for Bioprocess Development Using the BioAccord LC-MS System with ACQUITY Premier (p/n: 720007359)
    —Introducing a Rapid Throughput LC-MS Method for Cell Culture Media Nutrient and Metabolite Analysis Supporting Upstream Bioprocessing (p/n: 720008170)
  4. Intact protein analysis
    —ACQUITY UPLC and ACQUITY Premier Protein BEH C4, 300 Å Columns Care and Use Manual (p/n: 715001870)
  5. Released glycan analysis
    —GlycoWorks RapiFluo-MS N-Glycan Kit—24 Sample Care and Use Manual (p/n: 715004903)
    —Rapid Preparation of Released N Glycans for HILIC Analysis Using a Labeling Reagent that Facilitates Sensitive Fluorescence and ESI-MS Detection, Anal. Chem. 2015, 87, 5401−5409 DOI: 10.1021/acs.analchem.5b00758
  6. Protein A purification
    —Analytical Scale 96-well Protein A Affinity Resin-Based Purification using Andrew+ Automation Robot Supporting Upstream Bioprocessing, Waters application note 720009002
    —Automated High-Throughput Analytical-Scale Monoclonal Antibody Purification Using Production-Scale Protein A Affinity Chromatography Resin, Waters application note 720007861.
  7. JMP data visualization, MVA analysis
    —Transforming BioAccord LC-MS Quality Attribute & Cell Culture Analysis with JMP Workflows (in layout)

 

Featured Products

720008953, August 2025

Zurück zum Seitenanfang Zurück zum Seitenanfang